Comparison of Ebstein-Barr virus (EBV) Detection in Nasopharyngeal Carcinoma between Immunohistochemical Technique (IHC) and In Situ Hybridization Technique (ISH)

zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P. EBV DNA in biopsies of Burkitt’s tumors and anaplastic carcinomas of the nasopharynx. Nature 1970; 228: 1056-8.

Gulley ML, Glaser SL, Craig FE, Borowitz M, Mann RB, Shema SJ. Guidelines for interpreting EBER ISH and LMP1 IHC tests for detecting EBV in Hodgkin Lymphoma. Am J Clin Pathol. 2002; 117: 259-67.

Sadler RH, Raab-Traub N. Structural analyses of the EBV Bam HIA transcripts. J Viral. 1995;69: 1132-41.

Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cell.Cell 1985; 43: 831-40.

Cheung ST, Lo KW, Leung SF, Chan WY, Choi PH, Johnson PJ, et al. Prevalence of LMP1 detection variant of EBV in NPC and gastric tumors in Hong kong. Int J Cancer 1996; 66: 711-2.

Raab-Traub N. EBV in the pathogenesis of NPC. Sc min Cancer Biol 2002; 12: 431-41.

Chan JKC, Bray F, Mc Carron P, Foo W, Lee AWM, Yip T. Nasopharyngeal carcinoma. In: Barnes L, Eveson JW. Reichart P, Sidransky D, eds. Pathology and Genetics of Head and Neck Tumors. 1st ed. Albany. WHO Press; 2005.P. 81-97.

Klein G, Glovanella BC, Lindahl T. Direct evidence for the presence of EBV DNA and nuclear Ag in malignant epithelial cell from patients with poorly differentiated carcinoma of nasopharynx. Proc Nat Acad Sci USA 1974; 71: 4737-41.

Ho HC, Ng MH, Kwan HC, Chau JC. EBV specific IgA and IgG serum Ab in NPC. Br J Cancer 1976; 34: 655-60.

Arvanitakis L,Yaseen N and Sharma S. LMP1 induces cyclin D2 expression, and loss of TGF-beta 1-mediated growth inhibition in EBVpositive B cells. J Immunol 1955; 155: 1047-56.

Melino C, Cavallo R, Bergallo M. EBV virol load monitoring by quantitative PCR in renal transplant patients. New Microbiol 2003; 26: 141-9.

Fanaian NK, Cohen C, Waldrop S, Wang J, Shehata BM. EBV-encoded RNA:automated ISH compared with manual ISH and IHC for detection of detection of EBV in pediatric lymphoproliferative disorders. Pediatr Dev Pathol 2009; 12: 195-9.

Loughrey M, Trivett M, Lade S. Diagnostic application of EBV-encoded RNA ISH. Pathol 2004; 36: 301-8.

Lwanga SK., And Lemeshow S., 1991. Sample Size determination in health studies: A practical manual. Geneva: W.H.O. p25-42.

Lauritzen AF, Hording U, Nielsen HW. EBV and Hodgkin’sdisease: a comparative immunological, ISH and PCR study. AP MIS 1994; 102: 495-500.

Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, Jan JS.Quantification of plasma EBV DNA in patients with advanced NPC. N Engl J Med 2004;350: 2461-70.

Perez-Ordonez B. An update on EBV and NPC. Head Neck Pathol 2007;1: 141-5.

Clemens MJ. The small RNAs of EBV. Mol Biol Rep 1993;17: 61-81.